These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 15447999)

  • 1. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis.
    Takahashi T; Shivapurkar N; Riquelme E; Shigematsu H; Reddy J; Suzuki M; Miyajima K; Zhou X; Bekele BN; Gazdar AF; Wistuba II
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6126-33. PubMed ID: 15447999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic determination of CR1 CD35 density polymorphism on erythrocytes of patients with gallbladder carcinoma.
    Jiao XY; Lü MD; Huang JF; Liang LJ; Shi JS
    World J Gastroenterol; 2004 Dec; 10(23):3480-4. PubMed ID: 15526369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metagenomic Analysis of Biliary Microbial Flora in Patients with Gallbladder Cancer or Gallstones-Associated Chronic Cholecystitis.
    Shukla R; Tsuchiya Y; Behari A; Ikoma T; Nakamura K; Kapoor VK
    Cancer Invest; 2024 Jul; 42(6):478-490. PubMed ID: 38845533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter methylation profile in gallbladder cancer.
    Roa JC; Anabalón L; Roa I; Melo A; Araya JC; Tapia O; de Aretxabala X; Muñoz S; Schneider B
    J Gastroenterol; 2006 Mar; 41(3):269-75. PubMed ID: 16699861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNMT3A Cooperates with YAP/TAZ to Drive Gallbladder Cancer Metastasis.
    Xu S; Yuan Z; Jiang C; Chen W; Li Q; Chen T
    Adv Sci (Weinh); 2024 Apr; 11(16):e2308531. PubMed ID: 38380551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnosis of pancreatobiliary tract cancer by detecting mutations and methylation changes in bile samples.
    He S; Zeng F; Yin H; Wang P; Bai Y; Song Q; Chu J; Huang Z; Liu Y; Liu H; Chen Q; Liu L; Zhou J; Hu H; Li X; Li T; Wang G; Cai J; Jiao Y; Zhao H
    EClinicalMedicine; 2023 Jan; 55():101736. PubMed ID: 36425869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallbladder cancer.
    Roa JC; García P; Kapoor VK; Maithel SK; Javle M; Koshiol J
    Nat Rev Dis Primers; 2022 Oct; 8(1):69. PubMed ID: 36302789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of invasion-metastasis associated MiRNAs in gallbladder cancer by bioinformatics and experimental validation.
    Cao J; Shao H; Hu J; Jin R; Feng A; Zhang B; Li S; Chen T; Jeungpanich S; Topatana W; Tian Y; Lu Z; Cai X; Chen M
    J Transl Med; 2022 Apr; 20(1):188. PubMed ID: 35484565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RUNX3 Expression Level Is Correlated with the Clinical and Pathological Characteristics in Endometrial Cancer: A Systematic Review and Meta-analysis.
    Liu Z; Hong ZP; Xi SX
    Biomed Res Int; 2021; 2021():9995384. PubMed ID: 34337071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TMEFF2: A Transmembrane Proteoglycan with Multifaceted Actions in Cancer and Disease.
    Masood M; Grimm S; El-Bahrawy M; Yagüe E
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33371267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics/epigenomics and prevention by curcumin of early stages of inflammatory-driven colon cancer.
    Wu R; Wang L; Yin R; Hudlikar R; Li S; Kuo HD; Peter R; Sargsyan D; Guo Y; Liu X; Kong AN
    Mol Carcinog; 2020 Feb; 59(2):227-236. PubMed ID: 31820492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of Gallbladder Diseases with Sociodemographic Characteristics, Lifestyle, and Chronic Diseases in Northeastern China.
    Kang Q; Kang G; Li R; Zhu X; Yu Y; Yu Q
    Int J Environ Res Public Health; 2018 Nov; 15(11):. PubMed ID: 30469314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update.
    Sharma A; Sharma KL; Gupta A; Yadav A; Kumar A
    World J Gastroenterol; 2017 Jun; 23(22):3978-3998. PubMed ID: 28652652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation of
    Tekcham DS; Poojary SS; Bhunia S; Barbhuiya MA; Gupta S; Shrivastav BR; Tiwari PK
    Indian J Med Res; 2016 May; 143(Supplement):S82-S90. PubMed ID: 27748282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global and gene-specific DNA methylation pattern discriminates cholecystitis from gallbladder cancer patients in Chile.
    Kagohara LT; Schussel JL; Subbannayya T; Sahasrabuddhe N; Lebron C; Brait M; Maldonado L; Valle BL; Pirini F; Jahuira M; Lopez J; Letelier P; Brebi-Mieville P; Ili C; Pandey A; Chatterjee A; Sidransky D; Guerrero-Preston R
    Future Oncol; 2015; 11(2):233-49. PubMed ID: 25066711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of cholecystokinin A receptor in gallbladder cancer in the young and elderly suggests two subsets of the same disease?
    Kazmi HR; Chandra A; Baghel K; Singh A; Nigam J; Parmar D; Mahdi AA; Goel SK; Kumar S
    Biomed Res Int; 2014; 2014():625695. PubMed ID: 25025063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interplay between histone deacetylases and c-Myc in the transcriptional suppression of HPP1 in colon cancer.
    Wang J; Elahi A; Ajidahun A; Clark W; Hernandez J; Achille A; Hao JH; Seto E; Shibata D
    Cancer Biol Ther; 2014 Sep; 15(9):1198-207. PubMed ID: 24919179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic changes in carcinogenesis of gallbladder.
    Tewari M; Agarwal A; Mishra RR; Meena RN; Shukla HS
    Indian J Surg Oncol; 2013 Dec; 4(4):356-61. PubMed ID: 24426757
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.